Brian Halak
Founder chez Nobias Therapeutics, Inc.
Fortune : 1 275 $ au 31/03/2024
Profil
Brian K.
Halak is the founder of Nobias Therapeutics, Inc. (founded in 2020) and holds the title of Chairman.
He is also the founder of Domain Elite Holdings Ltd.
Dr. Halak's current jobs include Director positions at Life Sciences Pennsylvania, Corridor Pharmaceuticals, Inc., SMART Medical Systems Ltd., Medico Hong Kong Ltd., and SonoThera, Inc. He is also a Partner at Domain Associates LLC (since 2001), a Member at One Palmer Square Associates VI LLC, a Managing Member at One Palmer Square Associates VIII LLC, and the Managing Partner at Medical Excellence Capital LLC (since 2021).
Dr. Halak's former jobs include President, Chief Executive Officer & Director at WindMIL Therapeutics, Inc., Director at GI Dynamics, Inc., Independent Director at Alimera Sciences, Inc. (2004-2023), Director at Vanda Pharmaceuticals, Inc. (2004-2010), Director at Esprit Pharma, Inc., Director at Oraya Therapeutics, Inc., Director at Optherion, Inc., Independent Director at Dicerna Pharmaceuticals, Inc. (2010-2019), Director at Cortria Corp., Director at Fenway Pharmaceuticals, Inc., Director at Kona Medical, Inc., Director at Immune Control, Inc., Director at Carticept Medical, Inc., Director at Tobira Therapeutics, Inc., Director at Bionano Genomics, Inc., Director at Zyga Technology, Inc., Director at Oceana Therapeutics, Inc., Director at Eddingpharm (Cayman), Inc., Associate & Analyst at ATV Capital Management Inc. (2000-2001), Analyst at Wilkerson Group (1993-1995), Advisor at The Biotechnology Greenhouse Corp.
of Southeastern PA, Advisor at Ben Franklin Technology Partners, and Member-Advisory Board at Elm Street Advisors LLC.
Dr. Halak received a doctorate degree from Thomas Jefferson University in 2000 and an undergraduate degree from the University of Pennsylvania in 1993.
Dr. Halak is also the founder of Domain Elite Holdings Ltd...
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALIMERA SCIENCES, INC.
0,00% | 04/01/2023 | 327 ( 0,00% ) | 1 275 $ | 31/03/2024 |
Postes actifs de Brian Halak
| Sociétés | Poste | Début |
|---|---|---|
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Private Equity Investor | 01/01/2001 |
Nobias Therapeutics, Inc.
 Nobias Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nobias Therapeutics, Inc. develops drugs to cure rare illnesses in children. The American company was founded by Brian K. Halak. | Founder | 01/03/2020 |
SMART Medical Systems Ltd.
 SMART Medical Systems Ltd. Medical SpecialtiesHealth Technology SMART Medical Systems Ltd. manufactures medical devices. The firm’s products include naviaid platform, G-EYE, naviaid AB, naviaid ABC, inflation systems, controlled withdrawal nd future naviaid products. The company was founded by Gadi Terliuc in 205 and is headquartered in Ra’anana, Israel. | Director/Board Member | - |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Director/Board Member | - |
| One Palmer Square Associates VIII LLC | Corporate Officer/Principal | - |
| Medico Hong Kong Ltd. | Director/Board Member | - |
Medical Excellence Capital LLC
 Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Private Equity Investor | 01/04/2021 |
| One Palmer Square Associates VI LLC | Sales & Marketing | - |
Corridor Pharmaceuticals, Inc.
 Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Director/Board Member | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Brian Halak
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Brian Halak
| Thomas Jefferson University | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALIMERA SCIENCES, INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Entreprise privées | 31 |
|---|---|
GI Dynamics, Inc.
 GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
Esprit Pharma, Inc.
 Esprit Pharma, Inc. Pharmaceuticals: MajorHealth Technology Esprit Pharma, Inc. manufactures and supplies pharmaceutical products. The company offers SANCTURA, a treatment for over-active bladder and PRO-QUIN, a treatment for urinary tract infections. The company was founded in 2005 and is headquartered in East Brunswick, NJ. | Health Technology |
Oraya Therapeutics, Inc.
 Oraya Therapeutics, Inc. Medical SpecialtiesHealth Technology Oraya Therapeutics, Inc. develops and commercializes a non-invasive therapy for wet age-related macular degeneration. The firm delivers a precise dose of radiation non-invasively to the macula using an automated positioning system and a localizing algorithm. The company was founded by Michael E. Gertner in 2006 and is headquartered in Newark, CA. | Health Technology |
Optherion, Inc.
 Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Health Technology |
Fenway Pharmaceuticals, Inc.
 Fenway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fenway Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It provides drug development services. The company is headquartered in Newton, MA | Health Technology |
Kona Medical, Inc.
 Kona Medical, Inc. Medical/Nursing ServicesHealth Services Kona Medical, Inc. operates as a holding company, which engages in the design and development of non-invasive therapies for the treatment of hypertension. Its proprietary technology enables the ablation of renal nerves through the use of externally-delivered ultrasound energy. The company was founded by Michael Gertner in 2009 and is headquartered in Bellevue, WA. | Health Services |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
ATV Capital Management Inc.
 ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts. | Finance |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting private company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Health Services |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Immune Control, Inc.
 Immune Control, Inc. Pharmaceuticals: MajorHealth Technology Immune Control is an emerging pharmaceutical company developing novel, orally available, small molecules for autoimmune/inflammatory diseases. The company is commercializing the discovery that serotonin is a required growth factor for dividing lymphocytes. Certain serotonin antagonists eliminate activated or dividing T- or B-lymphocytes without disturbing resting lymphocytes. The ability to kill activated immune cells selectively has important implications for treating autoimmune/inflammatory diseases, hematologic cancers, and organ transplant rejection. Immune Control is a first-mover and the leader in the emerging field of serotonin-based immunotherapeutics. Their preclinical development program has yielded important insights into the design of orally available, potent, small molecules for autoimmune/inflammatory conditions. Immune Control is focused initially on two diseases: rheumatoid arthritis and asthma. Immune Control designs and develops novel compounds using in vitro and in vivo assays for receptor binding, efficacy, safety, and bioavailability. In 2008, the company plans to nominate two compounds as IND candidates for RA and asthma. In addition, they are conducting phase 1, proof-of-concept clinical trials in multiple myeloma and psoriasis, utilizing a currently approved serotonin antagonist. | Health Technology |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Carticept Medical, Inc.
 Carticept Medical, Inc. Medical SpecialtiesHealth Technology Carticept Medical, Inc. develops and markets medical devices. It develops platform technologies to improve the safety, efficiency, and accuracy of many common injection procedures. The firm's Navigator Delivery System, a FDA-cleared computer controlled medication delivery system for intra-articular injections. The company was founded by Timothy J. Patrick and Peter J. Pizzo, III in 2005 and is headquartered in Alpharetta, GA. | Health Technology |
| One Palmer Square Associates VI LLC | |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Zyga Technology, Inc.
 Zyga Technology, Inc. Medical SpecialtiesHealth Technology Zyga Technology, Inc. develops novel technology for resurfacing the facet and zygapophyseal joints. It engages in the development minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The firm offers GLYDER Facet Resurfacing System, an investigational device and is intended exclusively for clinical investigations. The company was founded by Robert Assell in March 2008 and is headquartered in Minneapolis, MN. | Health Technology |
Elm Street Advisors LLC
 Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Finance |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Health Technology |
| One Palmer Square Associates VIII LLC | |
Corridor Pharmaceuticals, Inc.
Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Health Technology |
Eddingpharm (Cayman), Inc.
 Eddingpharm (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong. | Health Technology |
Domain Elite Holdings Ltd.
 Domain Elite Holdings Ltd. Financial ConglomeratesFinance Domain Elite Holdings Ltd. engages in the provision of investment services with interest in healthcare and medical technologies. The firm invests in medical devices, in-vitro diagnostics, and pharmaceutical products. The company was founded by Brian K. Halak and is headquartered in Beijing, China. | Finance |
SMART Medical Systems Ltd.
SMART Medical Systems Ltd. Medical SpecialtiesHealth Technology SMART Medical Systems Ltd. manufactures medical devices. The firm’s products include naviaid platform, G-EYE, naviaid AB, naviaid ABC, inflation systems, controlled withdrawal nd future naviaid products. The company was founded by Gadi Terliuc in 205 and is headquartered in Ra’anana, Israel. | Health Technology |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Health Technology |
| Medico Hong Kong Ltd. | |
Nobias Therapeutics, Inc.
Nobias Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nobias Therapeutics, Inc. develops drugs to cure rare illnesses in children. The American company was founded by Brian K. Halak. | Health Technology |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Finance |
SonoThera, Inc.
 SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Health Technology |
